glp 1 and biologics GLP-1 Reporter Cells | Incretin Bioassay Current Insights, Advantages and Challenges

While semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound) transformed obesity treatment, Retatrutide adds a third receptor to the equation with potentially game-changing results

Gastroenterology 167 , 402404 (2024)

Skip over navigation You appear to have JavaScript disabled in your browser

I'm doing research on the GLP-1 connection with papillary right now, because I see patients with thyroid cancer who have obesity and they're at high risk for recurrent thyroid cancer

Recovery: 2 to 3 weeks

A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis